Scott AM - Search Results

1

Abnormalities at three musculoskeletal sites on whole-body positron emission tomography/computed tomography can diagnose polymyalgia rheumatica with high sensitivity and specificity.

Owen CE, Poon AMT, Yang V, McMaster C, Lee ST, Liew DFL, Leung JL, Scott AM, Buchanan RRC. Owen CE, et al. Among authors: scott am. Eur J Nucl Med Mol Imaging. 2020 Sep;47(10):2461-2468. doi: 10.1007/s00259-020-04731-z. Epub 2020 Feb 23. Eur J Nucl Med Mol Imaging. 2020. PMID: 32090280

2

Abnormal colonic accumulation of fluorine-18-FDG in pseudomembranous colitis.

Hannah A, Scott AM, Akhurst T, Berlangieri S, Bishop J, McKay WJ. Hannah A, et al. Among authors: scott am. J Nucl Med. 1996 Oct;37(10):1683-5. J Nucl Med. 1996. PMID: 8862310 Free article.

3

The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer.

Kiffer JD, Berlangieri SU, Scott AM, Quong G, Feigen M, Schumer W, Clarke CP, Knight SR, Daniel FJ. Kiffer JD, et al. Among authors: scott am. Lung Cancer. 1998 Mar;19(3):167-77. doi: 10.1016/s0169-5002(97)00086-x. Lung Cancer. 1998. PMID: 9631364 Clinical Trial.

4

F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer.

Berlangieri SU, Scott AM, Knight SR, Fitt GJ, Hennessy OF, Tochon-Danguy HJ, Clarke CP, McKay WJ. Berlangieri SU, et al. Among authors: scott am. Eur J Cardiothorac Surg. 1999 Sep;16 Suppl 1:S25-30. doi: 10.1016/s1010-7940(99)00179-7. Eur J Cardiothorac Surg. 1999. PMID: 10536941 Clinical Trial.

5

Current status of positron emission tomography in oncology.

Scott AM. Scott AM. Intern Med J. 2001 Jan-Feb;31(1):27-36. doi: 10.1046/j.1445-5994.2001.00015.x. Intern Med J. 2001. PMID: 11478353 Review.

6

Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma.

Ramdave S, Thomas GW, Berlangieri SU, Bolton DM, Davis I, Danguy HT, Macgregor D, Scott AM. Ramdave S, et al. Among authors: scott am. J Urol. 2001 Sep;166(3):825-30. J Urol. 2001. PMID: 11490227

7

Current status of positron emission tomography in oncology.

Scott AM. Scott AM. Australas Radiol. 2002 Jun;46(2):154-62. doi: 10.1046/j.1440-1673.2001.01025.x. Australas Radiol. 2002. PMID: 12060153 Review.

8

Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer.

Hannah A, Scott AM, Tochon-Danguy H, Chan JG, Akhurst T, Berlangieri S, Price D, Smith GJ, Schelleman T, McKay WJ, Sizeland A. Hannah A, et al. Among authors: scott am. Ann Surg. 2002 Aug;236(2):208-17. doi: 10.1097/00000658-200208000-00009. Ann Surg. 2002. PMID: 12170026 Free PMC article. Clinical Trial.

9

Positron emission tomography and epilepsy.

Casse R, Rowe CC, Newton M, Berlangieri SU, Scott AM. Casse R, et al. Among authors: scott am. Mol Imaging Biol. 2002 Oct;4(5):338-51. doi: 10.1016/s1536-1632(02)00071-9. Mol Imaging Biol. 2002. PMID: 14537108

10

Positron emission tomography scanning in the assessment of patients with lymphoma.

Foo SS, Mitchell PL, Berlangieri SU, Smith CL, Scott AM. Foo SS, et al. Among authors: scott am. Intern Med J. 2004 Jul;34(7):388-97. doi: 10.1111/j.1445-5994.2004.00614.x. Intern Med J. 2004. PMID: 15271172

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

744 results

Search Page

Filters